Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1963 Mar;16(2):120–123. doi: 10.1136/jcp.16.2.120

Insulin-binding antibodies in relation to insulin therapy

J N Harris-Jones 1,2,3, H Miller 1,2,3, G Owen 1,2,3
PMCID: PMC480511  PMID: 13952970

Abstract

Methods for detecting insulin binding or transporting antibodies are described, involving the use of radioactively labelled insulin (insulin 131I). These antibodies are detected in a high proportion of patients receiving insulin, particularly those requiring large doses. The protein fractions concerned appear to be the beta and gamma globulins. The significance of the phenomenon is discussed.

Full text

PDF
120

Images in this article

121Image
on p.121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERSON S. A., YALOW R. S., BAUMAN A., ROTHSCHILD M. A., NEWERLY K. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest. 1956 Feb;35(2):170–190. doi: 10.1172/JCI103262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERSON S. A., YALOW R. S. Species-specificity of human antibeef, pork insulin serum. J Clin Invest. 1959 Nov;38:2017–2025. doi: 10.1172/JCI103980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BURROWS B. A., PETERS T., LOWELL F. C. Physical binding of insulin by gamma globulins of insulin-resistant subjects. J Clin Invest. 1957 Mar;36(3):393–397. doi: 10.1172/JCI103435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FIELD J. B., TIETZE F., STETTEN D., Jr Further characterization of an insulin antagonist in the serum of patients in diabetic acidosis. J Clin Invest. 1957 Nov;36(11):1588–1593. doi: 10.1172/JCI103557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. KALANT N., GOMBERG C., SCHUCHER R. The effect of insulin-binding antibodies on insulin sensitivity. Lancet. 1958 Sep 20;2(7047):614–617. doi: 10.1016/s0140-6736(58)90337-4. [DOI] [PubMed] [Google Scholar]
  6. LOVELESS M., CANN J. R. Distribution of blocking antibody in human serum proteins fractionated by electrophoresis-convection. J Immunol. 1955 May;74(5):329–339. [PubMed] [Google Scholar]
  7. Lowell F. C. IMMUNOLOGIC STUDIES IN INSULIN RESISTANCE II. THE PRESENCE OF A NEUTRALIZING FACTOR IN THE BLOOD EXHIBITING SOME CHARACTERISTICS OF AN ANTIBODY. J Clin Invest. 1944 Mar;23(2):233–240. doi: 10.1172/JCI101486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MILLER H., OWEN G. The detection of insulin-binding antibodies in diabetic subjects on insulin therapy. Strahlentherapie. 1960;Suppl 45:266–278. [PubMed] [Google Scholar]
  9. McFARLANE A. S. Efficient trace-labelling of proteins with iodine. Nature. 1958 Jul 5;182(4627):53–53. doi: 10.1038/182053a0. [DOI] [PubMed] [Google Scholar]
  10. PEARSON J. D. Preparation of 131 I-labelled insulin. Lancet. 1959 May 9;1(7080):967–968. doi: 10.1016/s0140-6736(59)91081-5. [DOI] [PubMed] [Google Scholar]
  11. PEARSON J. D. Preparation of 131 I-labelled insulin. Lancet. 1959 May 9;1(7080):967–968. doi: 10.1016/s0140-6736(59)91081-5. [DOI] [PubMed] [Google Scholar]
  12. SKOM J. H., TALMAGE D. W. Nonprecipitating insulin antibodies. J Clin Invest. 1958 Jun;37(6):783–786. doi: 10.1172/JCI103664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. VALLANCE-OWEN J., DENNES E., CAMPBELL P. N. Insulin antagonism in plasma of diabetic patients and normal subjects. Lancet. 1958 Aug 16;2(7042):336–338. doi: 10.1016/s0140-6736(58)90257-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES